Objective
medulloblastoma
RECURRENCE, MEDULLOBLASTOMA, MEDULLOBLASTOMA
To evaluate the response rate of pediatric patients with medulloblastoma recurrence using an antiangiogenic metronomic combinatorial approach (Medulloblastoma European Multitarget Metronomic Anti-Angiogenic Trial [MEMMAT]).